Welcome to Invest in ME Research
Invest in ME is a UK charity facilitating and funding a strategy of biomedical research into Myalgic Encephalomyelitis (ME or ME/CFS) and promoting better education about ME.
For ten years the charity has been arranging an international CPD-accedited biomedical research conference on ME.
In 2015 IIMEC10 was the tenth annual conference arranged by the charity and now attracts presenters, researchers, physicians, patient groups and journalists from around the world.
In addition the charity organises an annual international research colloquium which aims to increase collaboration on research into ME.
On this site one will find a description of the conference, and links to previous conferences including details of the presenters.
Research into Myalgic Encephalomyelitis - specifically biomedical research into ME - has, thanks to conferences and research meetings organised by Invest in ME, emerged into the mainstream of of research and is receiving increasingly more attention from both major international research institutes in several countries as well as national health organisations.
Organisations responsible for medical research in several countries have stated that ME should receive more urgent attention.
In Norway the Norwegian Health Directorate have allocated funding for biomedical research into ME following the 2011 double blind randomised
clinical trial using Rituximab (Anti-CD20 monoclonal antibody) by Fluge et al (PLoS 6:10.Oct 2011) to successfully treat ME patients.
There is increasing research evidence of immune dysfunction in ME patients.
The UK MRC has previously stated - "There is now preliminary evidence supporting the view that inflammatory mechanisms in the brain and spinal cord may underlie the pathophysiology of some severe disease CFS/ME phenotypes." The IIMEC10 conference in 2015 showed some of the major initiatives being taken to set up a collaborative strategy for biomedical research into ME to further this complex but exciting area of research leading to appropriate patient care and mainstreaming this field of research as well as this disease.
WHO SHOULD ATTEND
The Invest in ME conferences appeal to healthcare professionals, doctors, nurses, paediatricians, occupational therapists, researchers, ME support groups, people with ME and those working in social services, educational support and the media. The conference provides an opportunity for people within government, health departments, social services and education to be able to be informed of the true nature of ME and of the current status of diagnosis, treatment and current/future biomedical research possibilities.
If help is needed regarding any aspect of the conferences please use our Contact Us page.
Our main web site is at www.investinme.org
PAST IiME CONFERENCES
All conferences are described on this web site.
The conference regularly attracts clinicians, researchers, healthcare staff, charities, support groups and patients and carers from twenty countries around the world.
This allows unique networking opportunities and increase the potential for one of the charity's main objectives - international collaboration between researchers.